Temsirolimus US FDA Label

  • Compound: [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate
  • Description: NA

Identifiers (11)

  • ClinPGx ID: PA164746890 (Source: ClinPGx)
  • Drug Central ID: 4161 (Source: PubChem)
  • KEGG Compound ID: C15182 (Source: J-Global)
  • KEGG Compound ID: C15182 (Source: Human Metabolome Database)
  • KEGG Drug ID: D06068 (Source: J-Global)
  • Metabolomics Workbench ID: 43668 (Source: PubChem)
  • Human Metabolomic Database ID: HMDB0015632 (Source: Human Metabolome Database)
  • Human Metabolomic Database ID: HMDB0015632 (Source: PubChem)
  • International Nonproprietary Name: TEMSIROLIMUS [INN] (Source: PubChem)
  • USFDA Precision ID: UNII-624KN6GM2T (Source: PubChem)
  • US Adopted Name: Temsirolimus [USAN] (Source: PubChem)

    • Sources: ClinPGx (1) PubChem (6) J-Global (2) Human Metabolome Database (2)